Zhengting Chen Selected Research

Fatigue

1/2021

Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy for Metastatic Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhengting Chen Research Topics

Disease

2	Neoplasms (Cancer) 01/2022 - 09/2019
1	Brain Neoplasms (Brain Tumor) 09/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2022
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Fatigue 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 04/2018
1	Rectal Neoplasms (Rectal Cancer) 04/2018

Drug/Important Bio-Agent (IBA)

1	7-methylguanosineIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Histones (Histone)IBA 01/2021
1	PlatinumIBA 01/2021
1	Lysine (L-Lysine)FDA Link 01/2021
1	Biomarkers (Surrogate Marker)IBA 04/2018
1	Therapeutic UsesIBA 04/2018

Therapy/Procedure

4	Radiotherapy 09/2022 - 04/2018
2	Drug Therapy (Chemotherapy) 01/2021 - 04/2018
1	Therapeutics 01/2021
1	Chemoradiotherapy 04/2018